🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
The aim of this study is to evaluate the efficacy and safety of TQB2102 com...
Status
Not Yet Recruiting
Location
Henan cancer hospital
Start Date
2025-09-01
Trial ID
NCT07136974
Treatments Being Tested
A study evaluating the safety, preliminary efficacy and pharmacokinetics of...
Status
Terminated
Location
HOPITAL JEAN MINJOZ; Oncologie
Start Date
2020-07-09
Trial ID
NCT04404140
Treatments Being Tested
This trial that is investigating a medication called duvelisib in combinati...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2021-10-14
Trial ID
NCT05057247
Triple-negative breast cancer (TNBC) is a special type of breast cancer, en...
Status
Completed
Location
Guangdong general hospital
Start Date
2018-08-01
Trial ID
NCT03243838
Treatments Being Tested
The main objective of this research is to increase the life expectancy of p...
Status
Recruiting
Location
Institut de Cancérologie de Lorraine
Start Date
2025-01-02
Trial ID
NCT06640725
Treatments Being Tested